Ajooni Biotech Receives Upgraded Credit Rating and Right Issue Details

Punjab (India), May 3:  Ajooni Biotech Limitedis thrilled to share that CRISIL Limited has raised company’s long-term credit facilities ratings to “CRISIL BB+/ Stable”. This upgrade underscores company’s ongoing efforts to improve risk profile, revenue streams, and operational profitability. It highlights the significant expertise of company’s promoters, strong customer partnerships, and favourable financial risk position. [...]

PNN
PNN Verified Media or Organization • 11 Apr, 2026 Agency
May 3, 2024 • 12:46 PM  0
S
Sangri Today Spotlight
BREAKING
PNN
PNN
2 years ago
Ajooni Biotech Receives Upgraded Credit Rating and Right Issue Details
Rating and Right Issue Details
Punjab (India), May 3:  Ajooni Biotech Limitedis thrilled to share that CRISIL Limited has raised company’s long-term credit facilities ratings to “CRISIL BB+/ Stable”. This upgrade underscores company’s ongoing efforts to improve risk profile, revenue streams, and operational profitability. It highlights the significant expertise of company’s promoters, strong customer partnerships, and favourable financial risk position. [...]
Full Story: https://www.sangritoday.com/spotlight/ajooni-biotech-receives-upgraded-credit-rating-and-right-issue-details
https://www.sangritoday.com/spotlight/ajooni-biotech-receives-upgraded-credit-rating-and-right-issue-details
Google News
Copied
Ajooni Biotech Receives Upgraded Credit Rating and Right Issue Details

Punjab (India), May 3:  Ajooni Biotech Limitedis thrilled to share that CRISIL Limited has raised company’s long-term credit facilities ratings to “CRISIL BB+/ Stable”. This upgrade underscores company’s ongoing efforts to improve risk profile, revenue streams, and operational profitability. It highlights the significant expertise of company’s promoters, strong customer partnerships, and favourable financial risk position. Although company recognize the potential impact of fluctuating raw material prices, they are fully committed to managing and minimizing such risks.

The Rights Issue details include a record date of May 7, 2024, with the Issue Opening Date set for May 21, 2024, and the Issue Closing Date slated for May 31, 2024. Market Renunciations can be made until May 27, 2024. The ratio for this Rights Issue stands at One Equity Share for every One Equity Share held (1:1), with an Issue Price of Rs. 5 per Rights Equity Share. The issue size amounts to Rs. 4,000.00 Lakhs, and the terms of payment require the full amount of Rs.  5.00 per equity share to be paid upon application.Company’s promoter is also equally participating in the rights issue.

Company will establish a new plant on a fresh industrial plot.

favorite Follow us for the latest updates:

PNN Verified Media or Organization • 11 Apr, 2026 Agency

(This is an unedited and auto-generated story from Syndicated News feed, Sangri Today Staff may not have modified or edited the content body)

home Home amp_stories Web Stories local_fire_department Trending play_circle Videos mark_email_unread Newsletter